Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA awards orphan drug designation to brincidofovir for the treatment of smallpox

June 8, 2018

Selinexor liposarcoma trial advances after improvement seen in progression-free survival

June 7, 2018

Enrollment ongoing in phase III study of pertuzumab and trastuzumab fixed-dose combination

June 7, 2018

GlaxoSmithKline initiates phase I study of GSK-3858279

June 7, 2018

Phase II results presented for TAK-954 in patients with enteral feeding intolerance

June 7, 2018

Athersys expands its collaboration with Healios

June 7, 2018

EMA grants PRIME designation for dilanubicel

June 7, 2018

FDA grants orphan drug designation to TransCon PTH

June 7, 2018

4D pharma and MSD collaborate to study Keytruda and MRx-0518 combination in solid tumors

June 7, 2018

Positive results presented from ongoing phase I trial of PTI-801 in patients with CF

June 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...